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Objectives
To investigate the importance of incorporating adaptive
designs of randomised phase II trials into the protocol
and patient information sheets using NEO-ESCAPE as
an illustrative example.
Methods
NEO-ESCAPE was a randomised two arm phase II study
in inoperable ovarian cancer designed as an external
pilot to inform a future phase III randomised controlled
trial. The primary objective was to assess the feasibility
of two new extended chemotherapy regimens with 44
patients required on each arm. If one or both treatment
arms proved feasible, the trial would continue to recruit
to the feasible treatment arm(s) to improve the esti-
mates of outcomes to be used in the phase III trial.
Stopping rules were essential to enable pre-planned
decisions on the futility of continuing to the required 44
patients on each arm. Simulations to assess futility were
used in the decision making process.
Results
At the first pre-planned interim analysis when 56
patients had been recruited (28 on each arm) and 21
patients (11 on Arm A; 10 on Arm B) had finished
treatment, it was clear that one arm of the trial would
not meet the feasibility criteria on completion of
recruitment. On the advice of the Independent Data
Monitoring Committee, this arm of the study closed
to recruitment but follow-up for these patients
continued.
Closure of one arm of the study resulted in a tempor-
ary halt of the trial while the protocol was amended to a
single arm study, the patient information sheet was
updated and all the relevant ethics, MHRA and Research
and Development approvals were obtained. This tem-
porary two month halt in recruitment to the study car-
ried not only a loss of potential patients during the
closed period but also a loss of momentum of centres
on re-opening of the study and hence resulted in a
delay in completing recruitment.
Conclusions
Our experiences with this phase II study emphasise the
need for full details of any adaptive designs, including
all anticipated scenarios and subsequent actions, to be
fully incorporated into the protocol and patient informa-
tion sheet to avoid the need for a temporary halt of
recruitment. A detailed statistical analysis plan is also
essential in ensuring optimal decision making within
these types of studies. The dilemma remains on how
best to achieve a seamless transition in the adaptive ele-
ment whilst not confusing patients with too much infor-
mation about each possible future adaptation.
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